Global CXCR4 Antagonists Market / Sector Size, Status and Forecast 2019-2025 (Includes Business Impact of COVID-19)
- TBI416918
- August 12, 2019
- Global
- 139 pages
- TSCIR
Abstract, Snapshot, Market Analysis & Market Definition: Global CXCR4 Antagonists Market
CXCR4 antagonists are small-molecule which block the CXCR4 receptors and prevent their activation. Blocking the receptors stop the receptors' ligand, CXCL12, from binding which prevent downstream effects. CXCR4 antagonists are especially important for hindering cancer progression because one of the downstream effects initiated by CXCR4 receptor activation is cell movement which lead to tumor growth and metastasis in cancer patients. The CXCR4 receptor has been targeted by antagonistic substances, these antagonists have prospective use as therapeutic drug agents, and are currently under development in labs worldwide. In 2018, the global CXCR4 Antagonists market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global CXCR4 Antagonists status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CXCR4 Antagonists development in United States, Europe and China.
Market Segmentation, Outlook & Viewpoint: Global CXCR4 Antagonists Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
BL-8040
GMI-1359
Plerixafor (AMD3100)
Balixafortide (POL6326)
USL311
Others
Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:
Cancer
HIV
Chronic Inflammatory Diseases
Top Companies & Key Players: Global CXCR4 Antagonists Market
Sanofi
BioLineRx
X4 Pharmaceuticals
Eli Lilly
Roche
Merck
Biokine Therapeutics
GlycoMimetics
Harmonic Pharma
Upsher-Smith Laboratories
Key Insights Covered: Global CXCR4 Antagonists Market
1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of CXCR4 Antagonists industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of CXCR4 Antagonists industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of CXCR4 Antagonists industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of CXCR4 Antagonists industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of CXCR4 Antagonists industry.
Research Methodology: Global CXCR4 Antagonists Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global CXCR4 Antagonists Market Size Growth Rate by Type (2014-2025) 1.4.2 BL-8040 1.4.3 GMI-1359 1.4.4 Plerixafor (AMD3100) 1.4.5 Balixafortide (POL6326) 1.4.6 USL311 1.4.7 Others 1.5 Market by Application 1.5.1 Global CXCR4 Antagonists Market Share by Application (2014-2025) 1.5.2 Cancer 1.5.3 HIV 1.5.4 Chronic Inflammatory Diseases 1.6 Study Objectives 1.7 Years Considered2 Global Growth Trends 2.1 CXCR4 Antagonists Market Size 2.2 CXCR4 Antagonists Growth Trends by Regions 2.2.1 CXCR4 Antagonists Market Size by Regions (2014-2025) 2.2.2 CXCR4 Antagonists Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities3 Market Share by Key Players 3.1 CXCR4 Antagonists Market Size by Manufacturers 3.1.1 Global CXCR4 Antagonists Revenue by Manufacturers (2014-2019) 3.1.2 Global CXCR4 Antagonists Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global CXCR4 Antagonists Market Concentration Ratio (CR5 and HHI) 3.2 CXCR4 Antagonists Key Players Head office and Area Served 3.3 Key Players CXCR4 Antagonists Product/Solution/Service 3.4 Date of Enter into CXCR4 Antagonists Market 3.5 Mergers & Acquisitions, Expansion Plans4 Breakdown Data by Type and Application 4.1 Global CXCR4 Antagonists Market Size by Type (2014-2019) 4.2 Global CXCR4 Antagonists Market Size by Application (2014-2019)5 United States 5.1 United States CXCR4 Antagonists Market Size (2014-2019) 5.2 CXCR4 Antagonists Key Players in United States 5.3 United States CXCR4 Antagonists Market Size by Type 5.4 United States CXCR4 Antagonists Market Size by Application6 Europe 6.1 Europe CXCR4 Antagonists Market Size (2014-2019) 6.2 CXCR4 Antagonists Key Players in Europe 6.3 Europe CXCR4 Antagonists Market Size by Type 6.4 Europe CXCR4 Antagonists Market Size by Application7 China 7.1 China CXCR4 Antagonists Market Size (2014-2019) 7.2 CXCR4 Antagonists Key Players in China 7.3 China CXCR4 Antagonists Market Size by Type 7.4 China CXCR4 Antagonists Market Size by Application8 Japan 8.1 Japan CXCR4 Antagonists Market Size (2014-2019) 8.2 CXCR4 Antagonists Key Players in Japan 8.3 Japan CXCR4 Antagonists Market Size by Type 8.4 Japan CXCR4 Antagonists Market Size by Application9 Southeast Asia 9.1 Southeast Asia CXCR4 Antagonists Market Size (2014-2019) 9.2 CXCR4 Antagonists Key Players in Southeast Asia 9.3 Southeast Asia CXCR4 Antagonists Market Size by Type 9.4 Southeast Asia CXCR4 Antagonists Market Size by Application10 India 10.1 India CXCR4 Antagonists Market Size (2014-2019) 10.2 CXCR4 Antagonists Key Players in India 10.3 India CXCR4 Antagonists Market Size by Type 10.4 India CXCR4 Antagonists Market Size by Application11 Central & South America 11.1 Central & South America CXCR4 Antagonists Market Size (2014-2019) 11.2 CXCR4 Antagonists Key Players in Central & South America 11.3 Central & South America CXCR4 Antagonists Market Size by Type 11.4 Central & South America CXCR4 Antagonists Market Size by Application12 International Players Profiles 12.1 Sanofi 12.1.1 Sanofi Company Details 12.1.2 Company Description and Business Overview 12.1.3 CXCR4 Antagonists Introduction 12.1.4 Sanofi Revenue in CXCR4 Antagonists Business (2014-2019) 12.1.5 Sanofi Recent Development 12.2 BioLineRx 12.2.1 BioLineRx Company Details 12.2.2 Company Description and Business Overview 12.2.3 CXCR4 Antagonists Introduction 12.2.4 BioLineRx Revenue in CXCR4 Antagonists Business (2014-2019) 12.2.5 BioLineRx Recent Development 12.3 X4 Pharmaceuticals 12.3.1 X4 Pharmaceuticals Company Details 12.3.2 Company Description and Business Overview 12.3.3 CXCR4 Antagonists Introduction 12.3.4 X4 Pharmaceuticals Revenue ... | read more...
Related Reports
